| Warfarin-associated intraventricular hemorrhage. | |
| | |
MedLine Citation:
|
PMID: 18173903 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: In this study, we have reviewed our experience with anticoagulation-associated intraventricular hemorrhage (IVH). Our goal was to determine if IVH is also an independent prognosticator of fatal outcome in patients with anticoagulation-associated intracerebral hemorrhage (ICH). METHODS: This study is a retrospective analysis of medical records and computed tomographic imaging. Eighty-eight patients with warfarin-associated ICH were analysed, including eight patients with predominant IVH. RESULTS: There was a very low rate of hemorrhage extension in patients with predominant IVH. Despite that, those patients had 50% 30 day mortality. Overall patients with ICH had 45% 30 day mortality. Ventricular extension raised mortality in ICH patients to 75%, while the absence of ventricular extension carried only 23% 30 day mortality. IVH was significantly associated with 30 day mortality (p<0.001). Panventricular extension was uniformly fatal in patients with ICH and carried 75% 30 day mortality in patients with predominant IVH. On a multivariate logistic regression model including age, ICH volume and IVH, ICH volume (p<0.001) and IVH (p = 0.003) remained independently associated with early mortality. CONCLUSION: Extension of anticoagulation-associated ICH into ventricular system caused a high mortality, especially in patients with panventricular involvement. IVH is an independent predictor of early death in these patients. In our experience, the majority of IVH do not expand over time and poor outcome appears to be related to the magnitude of the initial insult. |
| | |
Authors:
|
Alexander Zubkov; Daniel O Claassen; Alejandro A Rabinstein |
Related Documents
:
|
274993 - The ommaya reservoir: newly recognized complications and recommendations for insertion ... 10660023 - Vasospasm after cranial base tumor resection: pathogenesis, diagnosis, and therapy. 10349503 - Decreased phagocytic function in patients with parkinson's disease. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Neurological research Volume: 29 ISSN: 0161-6412 ISO Abbreviation: Neurol. Res. Publication Date: 2007 Oct |
Date Detail:
|
Created Date: 2008-01-04 Completed Date: 2008-02-19 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7905298 Medline TA: Neurol Res Country: England |
Other Details:
|
Languages: eng Pagination: 661-3 Citation Subset: IM |
Affiliation:
|
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Aged, 80 and over Anticoagulants / adverse effects* Brain / blood supply, pathology, physiopathology Cerebral Arteries / drug effects, pathology, physiopathology Cerebral Hemorrhage / chemically induced*, mortality* Choroid Plexus / drug effects, physiopathology Female Hospital Mortality / trends Humans Lateral Ventricles / blood supply, physiopathology*, radiography Male Predictive Value of Tests Prognosis Retrospective Studies Risk Factors Tomography, X-Ray Computed Warfarin / adverse effects* |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 81-81-2/Warfarin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Monitoring of cerebral metabolism: non-ischemic impairment of oxidative metabolism following severe ...
Next Document: In-hospital delays to stroke thrombolysis: paradoxical effect of early arrival.